Gynecologic Oncology | Interview with Krishnansu Tewari, MD

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Tewari on the following topic: Selection and sequencing of therapies for metastatic cervical cancer; mechanism of action, efficacy and tolerability of tisotumab vedotin (00:00) CME information and select publications